Edition:
United Kingdom

CASI Pharmaceuticals Inc (CASI.OQ)

CASI.OQ on NASDAQ Stock Exchange Capital Market

3.11USD
22 Mar 2019
Change (% chg)

$-0.23 (-6.89%)
Prev Close
$3.34
Open
$3.31
Day's High
$3.31
Day's Low
$3.11
Volume
63,048
Avg. Vol
88,497
52-wk High
$8.88
52-wk Low
$2.74

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 0.00 -0.101
Jun '18 0.00 -0.068
Mar '18 0.00 -0.050
FY 2017 Dec '17 0.00 -0.077
Sep '17 0.00 -0.027
Jun '17 0.00 -0.040
Mar '17 0.00 -0.028
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-19 3 7.97 10.85 3.42 12.11
Earnings (per share)
Quarter Ending Mar-19 1 -0.08 -0.08 -0.08 --
Quarter Ending Jun-19 1 -0.09 -0.09 -0.09 --
Year Ending Dec-19 3 -0.22 -0.15 -0.35 -0.02
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.32 32.54
P/E High - Last 5 Yrs. -- 147.73 48.15
P/E Low - Last 5 Yrs. -- 47.95 23.42
Beta 0.94 1.08 0.87
Price to Sales (TTM) -- 49.53 8.39
Price to Book (MRQ) 6.65 10.19 5.27
Price to Tangible Book (MRQ) 6.65 13.77 6.74
Price to Cash Flow (TTM) -- 56.16 24.12
% Owned Institutions 14.25 3.73 1.65

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.35
Dividend Yield - 5 Year Avg -- 0.09 1.37
Dividend 5 Year Growth Rate -- 0.78 4.70
Payout Ratio(TTM) -- 7.01 39.60

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 206.05 13.45
Sales (TTM) vs TTM 1 Yr. Ago -- 48.72 8.02
Sales - 5 Yr. Growth Rate -- 22.78 10.85
EPS (MRQ) vs Qtr. 1 Yr. Ago 47.85 75.14 47.68
EPS (TTM) vs TTM 1 Yr. Ago 40.88 -- --
EPS - 5 Yr. Growth Rate -- 11.98 10.47
Capital Spending - 5 Yr. Growth Rate 106.12 9.12 14.68

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.24 2.18
Current Ratio (MRQ) 7.90 3.50 2.98
LT Debt to Equity (MRQ) 0.00 19.47 11.35
Total Debt to Equity (MRQ) 8.78 32.15 16.02
Interest Coverage (TTM) -691.56 -43.13 28.44

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.25 52.41
Gross Margin - 5 Yr. Avg. -- 60.46 50.39
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -7,125.71 -110.45 12.43
Operating Margin (TTM) -- -185.04 5.77
Operating Margin - 5 Yr. Avg. -7,155.52 -126.93 8.02
Pre-Tax Margin (TTM) -- -175.74 4.80
Pre-Tax Margin - 5 Yr. Avg. -8,524.58 -132.72 8.31
Net Profit Margin (TTM) -- -182.45 1.53
Net Profit Margin - 5 Yr. Avg. -8,524.58 -137.11 4.72
Effective Tax Rate (TTM) -- 22.47 22.13
Effective Tax Rate - 5 Yr. Avg. -- 15.51 22.58

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 7,655,763 820,308,580
Net Income/Employee (TTM) -- 513,903 92,854,694
Receivable Turnover (TTM) -- 6.23 5.82
Inventory Turnover (TTM) -- 1.89 3.41
Asset Turnover (TTM) 0.00 0.32 0.90

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -39.33 6.37 10.60
Return on Assets - 5 Yr. Avg. -110.60 5.46 11.78
Return on Investment (TTM) -45.17 8.89 13.82
Return on Investment - 5 Yr. Avg. -119.58 6.77 15.32
Return on Equity (TTM) -62.67 10.02 15.24
Return on Equity - 5 Yr. Avg. -238.20 8.30 16.41
  1 Year 3 Year 5 Year
Sales % -100.00 -- --
EPS (TTM) % 23.82 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for CASI Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 79.05 72.87 97 99
13 Week 67.86 59.68 93 95
26 Week 67.86 55.10 88 98
52 Week 54.10 30.61 79 71
YTD 63.48 43.57 78 72
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 21.49%
# of Holders: 84
Total Shares Held: 20,113,093
3 Mo. Net Change: 709,919
# New Positions: 5
# Closed Positions: 16
# Increased Positions: 33
# Reduced Positions: 42
# Net Buyers: -9
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.